Photobiomodulation anti-inflammatory effect in COVID-19

INTERVENTION: Intervention 1: Intervention group: Photobiomodulation with red light on patients' chest , back and neck for 3 days each day for 15 minutes. The device named "Neolys" manufactured by "Life+" company in France. Intervention 2: Control group: The device is used for the intervention body location every day for 3 days each for 15 minutes but the device will not be turned‐on. CONDITION: COVID‐19. ; COVID‐19, virus identified U07.1 PRIMARY OUTCOME: IL‐1‐beta. Timepoint: Immediately before intervention, 12, 24, 48, 72 hours after intervention. Method of measurement: ELISA immunologic kit (produced by R&D company). IL‐10. Timepoint: Immediately before intervention, 12, 24, 48, 72 hours after intervention. Method of measurement: ELISA immunologic kit (produced by R&D company). IL‐12. Timepoint: Immediately before intervention, 12, 24, 48, 72 hours after intervention. Method of measurement: ELISA immunologic kit (produced by R&D company). IL‐8. Timepoint: Immediately before intervention, 12, 24, 48, 72 hours after intervention. Method of measurement: ELISA immunologic kit (produced by R&D company). Interleukin‐6. Timepoint: Immediately before intervention, 12, 24, 48, 72 hours after intervention. Method of measurement: ELISA immunologic kit (produced by R&D company). TGF‐beta. Timepoint: Immediately before intervention, 12, 24, 48, 72 hours after intervention. Method of measurement: ELISA immunologic kit (produced by R&D company). TNF‐alpha. Timepoint: Immediately before intervention, 12, 24, 48, 72 hours after intervention. Method of measurement: ELISA immunologic kit (produced by R&D company). INCLUSION CRITERIA: COVID‐19 Pneumonia Written consent Older than 15 years